Abiopharma

🔍 Gordon Crystal L (Executive)

Company: Gogo Inc. (GOGO)

Report Date: 2026-03-21

Detailed Transactions and Holdings:

• Acquired 43,801 shares of Common Stock (Direct)
  Date: 2026-03-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 86,461.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 12,592 shares of Common Stock at $4.26 per share (Direct)
  Date: 2026-03-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 73,869.00 | transaction_form_type: 4
• Sold 43,801 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 131,401.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: On March 21, 2025, the reporting person was granted 175,202 restricted stock units, vesting in four equal annual installments on the first four anniversaries of March 21, 2025, subject to continued employment with the Company.